Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547703 · ClinicalTrials.gov registry record · NA
Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00547703 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 5 participants.
The verdict
NCT00547703, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if use of Nortriptyline will improve symptoms and quality of life in patients who have nonulcer dyspepsia.
Interventions
- DRUG Placebo
- DRUG Nortriptyline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547703
The ClinicalTrials.gov registry entry for NCT00547703 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00547703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00547703 about?
NCT00547703 is a clinical study titled "Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia". The purpose of this study is to determine if use of Nortriptyline will improve symptoms and quality of life in patients who have nonulcer dyspepsia.
What is the current status of trial NCT00547703?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2008-02. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00547703?
The interventions under investigation include: Placebo (DRUG), Nortriptyline (DRUG).
Who is sponsoring clinical trial NCT00547703?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.